Sarepta Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	801.28	1,103	428.43	966.78	2,116
Short-Term Investments	138.37	251.78	1,248	1,023	-
Cash & Short-Term Investments	939.65	1,355	1,676	1,989	2,116
Cash Growth	-30.64%	-19.18%	-15.74%	-5.98%	9.15%
Accounts Receivable	398.23	636.6	430.11	256.39	171.64
Other Receivables	-	13.13	6.86	5.21	0.01
Receivables	398.23	649.73	436.98	261.6	171.65
Inventory	914.74	749.96	322.86	203.97	186.21
Prepaid Expenses	-	30.67	27.64	29.64	30.31
Other Current Assets	285.31	288.32	115.61	73.28	100.06
Total Current Assets	2,538	3,073	2,579	2,558	2,604
Property, Plant & Equipment	470.62	488.65	357.11	244.99	236.69
Long-Term Investments	1.05	136.87	6.53	31.32	34.89
Other Intangible Assets	-	26.89	29.62	7.58	14.24
Other Long-Term Assets	340.1	237.3	291.99	286.62	258.06
Total Assets	3,350	3,963	3,265	3,128	3,148
Accounts Payable	280.84	214.44	164.92	95.88	76.74
Accrued Expenses	359.66	241.66	197.93	335.67	206.45
Current Portion of Long-Term Debt	-	-	105.48	-	-
Current Portion of Leases	11.39	13.27	-	15.49	-
Current Income Taxes Payable	-	17.39	13.77	12.52	0.22
Current Unearned Revenue	443.4	130.26	50.42	89.24	89.24
Other Current Liabilities	-	114.66	121.15	70.8	80.08
Total Current Liabilities	1,095	731.68	653.66	619.6	452.73
Long-Term Debt	828.97	1,137	1,133	1,544	1,097
Long-Term Leases	199.38	192.47	140.97	57.58	41.51
Long-Term Unearned Revenue	83.91	325	437	485	574.24
Other Long-Term Liabilities	1.53	49.15	41.1	36.94	54.6
Total Liabilities	2,209	2,435	2,405	2,743	2,220
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	6,043	5,739	5,305	4,297	4,135
Retained Earnings	-4,877	-4,211	-4,446	-3,910	-3,207
Treasury Stock	-25.26	-	-	-	-
Comprehensive Income & Other	0.27	-0.22	0.92	-1.66	-0.02
Shareholders' Equity	1,141	1,528	859.34	384.95	928.01
Total Liabilities & Equity	3,350	3,963	3,265	3,128	3,148
Total Debt	1,040	1,343	1,379	1,617	1,138
Net Cash (Debt)	-100.1	11.92	297.29	372.02	977.48
Net Cash Growth	-	-95.99%	-20.09%	-61.94%	12.91%
Net Cash Per Share	-1.00	0.11	3.22	4.25	12.03
Filing Date Shares Outstanding	104.96	97.03	93.86	87.98	87.15
Total Common Shares Outstanding	104.96	96.9	93.73	87.95	87.13
Working Capital	1,443	2,342	1,926	1,938	2,151
Book Value Per Share	10.87	15.77	9.17	4.38	10.65
Tangible Book Value	1,141	1,501	829.72	377.37	913.77
Tangible Book Value Per Share	10.87	15.49	8.85	4.29	10.49
Land	-	10.17	10.17	5.18	5.18
Buildings	-	51.18	48.06	47.94	47.61
Machinery	-	141.98	118.63	102.31	75.04
Construction In Progress	-	165.9	91.09	23.59	25.16
Leasehold Improvements	-	155.07	99.99	97.33	103.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.